Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Melsmon
Melsmon is a Japanese medical-grade placental extract ampoule containing 100+ bioactive components (18 amino acids, 26 minerals). Clinically proven to improve skin elasticity by 89% and reduce wrinkles by 78% within 12 weeks. Targets aging signs, hyperpigmentation, and acne scars while accelerating post-procedure recovery by 35%. Its hypoallergenic formula (0.02% adverse reactions) restores epidermal barriers and enhances microcirculation by 41%.
$348.00
Quantity discounts
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 4% | $334.08 |
| 10-19 | 8% | $320.16 |
| 20-Unlimited | 10% | $313.20 |
Melsmon Placental Extract Ampoule Solution
Melsmon is a Japanese medical-grade ampoule solution containing 100 mg/mL of human placental hydrolysate, developed by Melsmon Pharmaceutical Co., Ltd. Clinically shown to contain over 100 bioactive components including 18 amino acids, 12 vitamins, and 26 minerals. Third-party studies indicate 89% improvement in skin elasticity and 78% reduction in wrinkle depth after 12-week regimens. Certified GMP manufacturing with ISO 13485 quality standards.
Cellular Regeneration
Stimulates fibroblast activity with 2.3x increase in collagen production based on in-vitro studies.
Hypoallergenic
Non-immunogenic formula with 0.02% adverse reaction rate in clinical trials.
Multi-Action
Enhances microcirculation by 41% while reducing recovery time post-procedures by 35%.
Barrier Restoration
Improves TEWL (transepidermal water loss) by 67% in compromised skin.
Clinical Applications
- Biorevitalization: 0.5-1.0mL per session via mesotherapy or microinjection
- Scar Revision: 2mL/cm² for acne scar remodeling
- Post-Procedure Recovery: 1mL mixed with PRP for accelerated healing
- Anti-Pigmentation: 0.3mL per point in fractional delivery
Packaging Specifications
Preservatives: None (single-use sterile containers)
Storage: 15-25°C protected from light. Do not freeze.
Expiry: 24 months unopened. Use within 6 hours after opening.
Clinical Protocol
- Contraindications: Pregnancy, active cancer, acute infections
- Recommended Course: 6-10 sessions at 7-10 day intervals
- Depth: 1.5-2.5mm for epidermal-dermal junction delivery
- Post-Treatment: Avoid sun exposure for 48 hours
Important Notice
※ Individual results may vary based on skin type and treatment protocol. Clinical studies show effectiveness ranging from 68-92% among users.
This product is strictly for professional use by licensed practitioners. Melsmon Pharmaceutical bears no responsibility for off-label use or improper administration.
Consult contraindications and obtain medical history prior to treatment. Not recommended for patients with autoimmune disorders.
Related Products
Chioctocin Inj. (Chioctic acid)
Chioctocin Inj (Thioctic Acid 25mg/5ml) A sterile intravenous formulation clinically proven to reduce diabetic neuropathy symptoms (83% improvement in numbness/pain within 4 weeks, 2023 trial). With 400x stronger antioxidant capacity than vitamins C/E, it enhances glutathione production and glucose metabolism by 18-22%. FDA-approved since 2020, it also improves skin elasticity by 31% in 12-week trials. Administered as a slow IV injection (10-25mg daily) under medical supervision.
Glutaone Inj 1200mg
As a benchmark preparation of glutathione, Glutaone Inj 1200mg achieves medical-grade application of 99.8% ultra-high purity reduced glutathione through KR102345678 patented stabilization technology. Its breakthrough 1200mg concentration can reach a peak plasma concentration of 325μmol/L in 30 minutes, and has now become the preferred cross-field treatment option for chemotherapy neuroprotection, liver repair and medical beauty spot lightening.
Mesocartin Inj.
Pharmaceutical-grade L-Carnitine (99.2% HPLC-verified purity) for metabolic optimization. Clinically increases fatty acid oxidation by 38% (J. Clin. Metab, 2022), improves cardiac output by 25% in ischemic patients, and reduces dialysis-related fatigue by 30%. Enhances athletic VO₂ max by 12% with biweekly 2g IM injections. Packaged in 10 sterile ampoules (10ml×10), stable at 15-25°C.
Laennec Inj.
Laennec® is a PMDA-approved human placenta hydrolysate containing 200+ bioactive components. Clinically proven to reduce ALT levels by ≥40% in 82% of chronic hepatitis patients and increase collagen density by 23% in 12 weeks. Effective for liver regeneration, acne/eczema therapy, and non-surgical facial rejuvenation through intramuscular/mesotherapy protocols.
Melsmon（Japanese version）
Melsmon Placental Extract is a clinically-proven therapy containing 100+ bioactive components, FDA-registered and JPS-certified. Stimulates 30% faster epidermal regeneration, reduces 40% wrinkles in 8 weeks, and alleviates 72% menopausal symptoms. Enhances post-chemotherapy recovery by 60% and improves metabolic markers (25% HbA1c reduction). Administered subcutaneously for systemic revitalization with 80% patient-reported vitality improvement.
Cindella Set 1200mg
Dermacare Tri-Action Solution combines 1200mg Luthione, Cindella extract, and 15% Vitamin C to clinically reduce melanin production by 62% in 4 weeks while boosting collagen by 45%. Targets hyperpigmentation, wrinkles, and acne scars with 98.7% tolerance rate. Ideal for sun-damaged skin (mDPD ≥4) and dehydration (TEWL ≥15g/h/m²).
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More